Harry Lam Location
- Taipei City, Taiwan
Harry Lam Work
- 2024 - now Senior Technology Advisor @
- 2023 - now Founder and CEO @ FAST Cell Therapy, Inc.
- 2022 - 2025 CTO, EVP Technical Operations @
- 2018 - 2022 CTO, EVP Technical Operations @
- 2017 - 2018 Director, Head of Therapeutics Technical Operations @
- 2016 - 2017 CTO, VP CMC Development @ Affinita Biotech
- 2015 - 2016 VP, Head of Manufacturing, Biologics @
- 2014 - 2015 Vice President, Manufacturing Development and Technical Operations @ Progenitor Cell Therapy
- 2014 - 2014 Senior Vice President, Technical Operations @ KaloBios
- 2013 - 2014 Vice President, Head of Manufacturing @ Shire Regenerative Medicine
- 2012 - 2013 Head Commercial Drug Substance CMO @
- 2010 - 2012 Senior Director, Global Biologics Drug Substance Manufacturing Science and Technology @
- 2007 - 2010 Director, Manufacturing and Technology @ Roche Singapore Technical Operation
- 2003 - 2007 Director, Biochemical Technology @
- 2003 - 2003 Director, Biochemical Manufacturing Operations @
- 2001 - 2003 Associate Director, Fermentation Operations @
- 1998 - 2001 Group Leader, Manufacturing Science and Technology @
Harry Lam Education
- Rensselaer Polytechnic Institute
PhD (Chemical Engineering)
- University of Birmingham
BSc (Chemical Engineering)
Harry Lam Skills
- Validation
- Technology Transfer
- Process Simulation
- FDA
- Manufacturing
- Biopharmaceuticals
- Pharmaceutical Industry
- Biochemistry
- Leadership
- Cross-functional Team Leadership
- Biotechnology
- Process Improvement
- GMP
- Operational Excellence
- R&D
- Fermentation
- Process Engineering
- Sop
- Change Control
- Purification
- 21 CFR Part 11
- Chromatography
- GLP
- Medical Devices
- Commercialization
- Quality System
- Protein Purification
- Drug Development
- Vaccines
- CAPA
- V&V
- Computer System Validation
- Lifesciences
- LIMS
- GxP
- HPLC
- Protein Chemistry
- Life Sciences
- Data Validation
- Simulation
- Business Development
- Project Management
- SQL
- Requirements Analysis
- Cross Functional Team Leadership
- Technology
Harry Lam Summary
- Harry Lam, based in Taipei City, Taiwan, is currently a Founder and CEO at FAST Cell Therapy, Inc.. Harry Lam brings experience from previous roles at JW Therapeutics 药明巨诺, Acepodia and 23andMe. Harry Lam holds a PhD in Chemical Engineering @ Rensselaer Polytechnic Institute. With a robust skill set that includes Validation, Technology Transfer, Process Simulation, FDA, Manufacturing and more. Harry Lam has 2 emails and 1 mobile phone numbers on RocketReach.
5 free lookup(s).
No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Looking for a different Harry Lam?
Find contact details for 700 million professionals.
Others Named Harry Lam
Harry Lam
Vice President of Risk Operations and Change Management
Greenwich, CT, US
Harry Lam
CEO and Co-Owner
San Diego, CA, US
Harry Lam
Chief Executive Officer
Hong Kong
Harry Lam
Senior Analyst, Enterprise Solution Delivery
Richmond Hill, ON, CA
Harry Lam
AVP HNW Operations
Hong Kong
Harry Lam
Backend Engineer
United Kingdom
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups. 
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension. 
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API. 
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co